Emerald Advisers LLC Reduces Position in Sientra Inc (SIEN)

Share on StockTwits

Emerald Advisers LLC reduced its stake in shares of Sientra Inc (NASDAQ:SIEN) by 7.0% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 25,100 shares of the medical instruments supplier’s stock after selling 1,900 shares during the period. Emerald Advisers LLC owned approximately 0.09% of Sientra worth $319,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. BlackRock Inc. increased its position in shares of Sientra by 5.5% in the third quarter. BlackRock Inc. now owns 1,572,899 shares of the medical instruments supplier’s stock valued at $37,561,000 after acquiring an additional 82,312 shares during the period. Vanguard Group Inc. increased its position in shares of Sientra by 1.4% during the third quarter. Vanguard Group Inc. now owns 1,017,312 shares of the medical instruments supplier’s stock valued at $24,293,000 after buying an additional 14,422 shares during the period. Vanguard Group Inc increased its position in shares of Sientra by 1.4% during the third quarter. Vanguard Group Inc now owns 1,017,312 shares of the medical instruments supplier’s stock valued at $24,293,000 after buying an additional 14,422 shares during the period. Northern Trust Corp increased its position in shares of Sientra by 74.2% during the second quarter. Northern Trust Corp now owns 270,559 shares of the medical instruments supplier’s stock valued at $5,278,000 after buying an additional 115,283 shares during the period. Finally, United Services Automobile Association increased its position in shares of Sientra by 17.7% during the third quarter. United Services Automobile Association now owns 237,529 shares of the medical instruments supplier’s stock valued at $5,672,000 after buying an additional 35,760 shares during the period. 86.77% of the stock is owned by institutional investors.

Several equities analysts recently issued reports on the stock. ValuEngine cut shares of Sientra from a “buy” rating to a “hold” rating in a research report on Tuesday, February 5th. Zacks Investment Research upgraded shares of Sientra from a “sell” rating to a “hold” rating in a research report on Wednesday, November 7th. BidaskClub lowered shares of Sientra from a “hold” rating to a “sell” rating in a research note on Tuesday, November 13th. Finally, Maxim Group raised shares of Sientra from a “hold” rating to a “buy” rating in a research note on Wednesday, December 19th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $22.50.

Shares of NASDAQ SIEN opened at $10.25 on Friday. Sientra Inc has a 52-week low of $8.79 and a 52-week high of $26.79. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.34 and a current ratio of 2.77.

COPYRIGHT VIOLATION NOTICE: “Emerald Advisers LLC Reduces Position in Sientra Inc (SIEN)” was originally posted by Fairfield Current and is the property of of Fairfield Current. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at https://www.fairfieldcurrent.com/news/2019/02/10/emerald-advisers-llc-has-319000-stake-in-sientra-inc-sien.html.

Sientra Profile

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

Further Reading: How to Profit and Limit Losses With Stop Orders

Institutional Ownership by Quarter for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply